Sumitomo Seika Chemicals (4008) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
6 Aug, 2026Review of previous medium-term business plan (FY2023–FY2025)
Achieved record-high operating profit in FY2025, exceeding target by 20.8%.
Net sales and ROE targets for FY2025 were not met, mainly due to extraordinary losses.
Strategic investments made in new SAP facilities and a research building.
Super Absorbent Polymers and Functional Materials sales volumes fell short of targets.
Favorable exchange rates and raw material prices contributed to profit, but net income target was missed.
Long-term vision 2045 and scenario planning
Vision set for 2045, aiming to build on technology and quality for sustainable growth.
Scenario planning conducted to prepare for uncertainties in raw materials and product value assessment.
Four future scenarios developed, focusing on energy sourcing and product traceability.
Commitment to solving global and societal issues through chemistry.
Emphasis on adapting strategies for resilience in changing business environments.
Material issues and five priority initiatives (FY2026–FY2030)
Key issues: reducing GHG emissions, advancing resource circulation, and supporting advanced industries.
Focus on creating next-generation businesses via R&D and innovation.
Quality, compliance, safety, and human capital highlighted as foundational.
Five priority initiatives: portfolio optimization, new business creation, sustainability management, robust management, and capital efficiency.
Specific KPIs and initiatives to be announced in November 2026.
Latest events from Sumitomo Seika Chemicals
- Strong sales and profit growth, but FY2027 outlook tempered by rising costs and global risks.4008
Q1 20276 Aug 2026 - Sales and operating profit rose, but profit fell on one-time losses; outlook cautious.4008
Q4 202520 Jul 2026 - Profits and shareholder returns rose, but outlook is uncertain due to Middle East risks.4008
Q4 202620 Jul 2026 - Operating profit rose despite lower sales, with strong shareholder returns and capacity expansion.4008
Q2 202520 Jul 2026 - Operating profit up 19.9% despite 1.7% sales drop; profit hit by mischarging provision.4008
Q2 202620 Jul 2026 - Profits fell sharply on lower sales and business exits, but full-year profit is forecast to recover.4008
Q1 202520 Jul 2026 - Profits surged on strong polymer sales and FX gains, prompting an upward revision to forecasts.4008
Q3 202520 Jul 2026 - Profits fell sharply year-over-year, but full-year net profit is forecast to rise on one-time factors.4008
Q1 202620 Jul 2026 - Operating profit rose 18.7% despite lower sales, with full-year profit forecast revised upward.4008
Q3 202620 Jul 2026